global pharmaceutical company
Monitoring issues related to the Bipartisan Budget Act of 2019, H.R.3877, P.L.116-37 and the Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, H.R.4378, P.L.116-59. Issues related to the pharmaceutical industry including drug pricing, drug value, and the 340B Program.
Issues related to healthcare policy and cost; Lower Health Care Costs Act of 2019, S.1895. Issues related to the implementation of the Tax Cuts and Jobs Act, P.L.115-97. Issues related to Medicare Part D coverage and reimbursement policies.
Issues related to Medicaid reimbursement.
Issues related to drug pricing; Prescription Drug Pricing Reduction Act of 2019, S.2543.
BUD - Budget/Appropriations PHA - Pharmacy TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
1 - SENATE 1 - SENATE 1 - SENATE 1 - SENATE
THE SIMMONS & RUSSELL GROUP, LLC
601 Pennsylvania Avenue, NW, South Building, Suite 900, Washington, DC, 20004, US
ROBERT A RUSSELL KYLE SIMMONS ROBERT A RUSSELL KYLE SIMMONS ROBERT A RUSSELL KYLE SIMMONS ROBERT A RUSSELL KYLE SIMMONS